KRAS and familial pancreatic carcinoma: We next examined the effects of KRB-456 on the levels of KRAS bound to GTP and on the binding of KRAS to RAF1 in intact Panc0203 and Panc1 human pancreatic cancer cells that harbor mt KRAS G12D.